Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060756

SVP, Chief Accounting Officer sold 140 shares at $81.14 ($11,360)

  • SVP, Chief Accounting Officer gave 819 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-13 Gift : show line 1 in the form −819 14,212 D
2021-10-14 Sale : show line 2 in the form −140 $81.14 $11,360 14,072 D
Open-market sales · 140 sh · avg $81.14 · $11,360
Loading xslF345X03/doc4.xml…